Role of α1-proteinase inhibitor in restraining peritoneal inflammation in CAPD patients
- 1 September 1992
- journal article
- Published by Elsevier in Kidney International
- Vol. 42 (3) , 735-742
- https://doi.org/10.1038/ki.1992.341
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Leukotriene B4 and Tumor Necrosis Factor Release from Leukocytes: Effect of Peritoneal DialysateNephron, 1991
- Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor αKidney International, 1990
- Platelet activating factor is produced during infectious peritonitis in CAPD patientsKidney International, 1989
- Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet‐activating factorEuropean Journal of Biochemistry, 1989
- Tissue Destruction by NeutrophilsNew England Journal of Medicine, 1989
- Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.The Journal of Experimental Medicine, 1987
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- Elastolytic Activity in Pulmonary Lavage Fluid from Patients with Adult Respiratory-Distress SyndromeNew England Journal of Medicine, 1981
- The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin DeficiencyScandinavian Journal of Clinical and Laboratory Investigation, 1963
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959